Related Experiment Video
Updated: May 13, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Damage-associated molecular patterns derived from mitochondria may contribute to the hemodialysis-associated
Theodoros Eleftheriadis1, Georgios Pissas, Georgia Antoniadi
1Department of Nephrology, Medical School, University of Thessaly, Neo Ktirio, Mezourlo Hill, 41110, Larissa, Greece, teleftheriadis@yahoo.com.
Purpose:
Inflammation is common in hemodialysis (HD) patients. Mitochondrial damage-associated molecular patterns (DAMPs) are released during cell necrosis or apoptosis and induce inflammation. Cell apoptosis is increased in HD patients. The mitochondrial protein cytochrome c, as a marker of released mitochondrial DAMPs, and interleukin-6 (IL-6), as a marker of inflammation, were evaluated in HD patients.
Methods:
Thirty-four HD patients and 20 controls were enrolled in the study. Serum cytochrome c and IL-6 were measured by means of enzyme-linked immunosorbent assay.
Results:
Compared to controls, cytochrome c was markedly increased in HD patients (1392.88 ± 905.24 pg/mL vs. 212.95 ± 91.71 pg/mL). IL-6 was also significantly increased in HD patients (50.32 ± 35.89 pg/mL vs. 14.27 ± 6.83 pg/mL). In HD patients serum IL-6 was positively related to serum cytochrome c (r = 0.458).
Conclusion:
Both circulating cytochrome c and IL-6 are markedly increased in HD patients. Cytochrome c is positively related to IL-6.
Insights
Mitochondrial damage-associated molecular patterns (DAMPs) like cytochrome c and inflammation marker IL-6 are elevated in hemodialysis (HD) patients. Increased cytochrome c correlates with higher IL-6 levels in HD patients.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Inflammation is a frequent complication in patients undergoing hemodialysis (HD).
- Mitochondrial damage-associated molecular patterns (DAMPs) contribute to inflammation, released during cell death.
- Increased cellular apoptosis in HD patients suggests elevated DAMPs release.
Purpose of the Study:
- To evaluate serum levels of cytochrome c, a marker of mitochondrial DAMPs, in HD patients.
- To assess serum levels of interleukin-6 (IL-6), a marker of inflammation, in HD patients.
- To investigate the relationship between cytochrome c and IL-6 in HD patients.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure serum cytochrome c and IL-6.
- The study included 34 patients undergoing hemodialysis and 20 healthy controls.
Main Results:
- Serum cytochrome c levels were significantly higher in HD patients compared to controls (1392.88 ± 905.24 pg/mL vs. 212.95 ± 91.71 pg/mL).
- Serum IL-6 levels were also significantly elevated in HD patients compared to controls (50.32 ± 35.89 pg/mL vs. 14.27 ± 6.83 pg/mL).
- A positive correlation was observed between serum cytochrome c and IL-6 levels in HD patients (r = 0.458).
Conclusions:
- Both circulating cytochrome c and IL-6 are markedly increased in hemodialysis patients.
- Elevated cytochrome c levels are positively associated with increased IL-6 levels in HD patients, suggesting a link between mitochondrial damage and inflammation.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis I: Introduction
Diabetic Nephropathy
Myocarditis I: Introduction
Dialysis
